Aging-induced pseudouridine synthase 10 impairs hematopoietic stem cells

• Published in: Haematologica (Roma) Vol. 108; no. 10; pp. 2677 - 2689
• Main Authors: Wang, Yuqian, Zhang, Zhenzhen, He, Hanqing, Song, Jinghui, Cui, Yang, Chen, Yunan, Zhuang, Yuan, Zhang, Xiaoting, Li, Mo, Zhang, Xinxiang, Zhang, Michael Q., Shi, Minglei, Yi, Chengqi, Wang, Jianwei
• Format: Journal Article
• Language: English
• Published: Italy Fondazione Ferrata Storti 01.10.2023; Ferrata Storti Foundation
• Subjects: Hematopoiesis
• ISSN: 0390-6078; 1592-8721; 1592-8721
• DOI: 10.3324/haematol.2022.282211

Aged hematopoietic stem cells (HSC) exhibit compromised reconstitution capacity and differentiation-bias towards myeloid lineage, however, the molecular mechanism behind it remains not fully understood. In this study, we observed that the expression of pseudouridine (Ψ) synthase 10 is increased in aged hematopoietic stem and progenitor cells (HSPC) and enforced protein of Ψ synthase 10 (PUS10) recapitulates the phenotype of aged HSC, which is not achieved by its Ψ synthase activity. Consistently, we observed no difference of transcribed RNA pseudouridylation profile between young and aged HSPC. No significant alteration of hematopoietic homeostasis and HSC function is observed in young Pus10-/- mice, while aged Pus10-/- mice exhibit mild alteration of hematopoietic homeostasis and HSC function. Moreover, we observed that PUS10 is ubiquitinated by E3 ubiquitin ligase CRL4DCAF1 complex and the increase of PUS10 in aged HSPC is due to aging-declined CRL4DCAF1- mediated ubiquitination degradation signaling. Taken together, this study for the first time evaluated the role of PUS10 in HSC aging and function, and provided a novel insight into HSC rejuvenation and its clinical application.